Description:

AMC-078 Adverse Events Form (ADV) Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9A357A24-85C8-31A4-E040-BB89AD4314CA

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9A357A24-85C8-31A4-E040-BB89AD4314CA

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Anal Cancer NCT01249443 Toxicity - AMC-078 Adverse Events Form (ADV) - 3184680v1.0

No Instruction available.

  1. StudyEvent: AMC-078 Adverse Events Form (ADV)
    1. No Instruction available.
Header
Unnamed2
Was this event expected or anticipated
CTC Adverse Event Attribution Code
Alternative etiology
Action Taken at Time of Adverse Event (check "Yes" for all that apply)
If modification was made to study therapy, who initiated modification
Unnamed3
Outcome of Adverse Event
Was this considered a Serious Adverse Event
Seriousness Attributed to Adverse Event (If "Yes" check "Yes" for all that apply Please note that checking "Yes" to any of the events below will require SAE notification according to protocol requirements.)
Comments